ImportRefusal LogoImportRefusal

Thymoorgan Pharmazie Gmbh

⚠️ Moderate Risk

FEI: 3002320821 • Goslar, Lower Saxony • GERMANY

FEI

FEI Number

3002320821

📍

Location

Goslar, Lower Saxony

🇩🇪

Country

GERMANY
🏢

Address

Schiffgraben 23, , Goslar, Lower Saxony, Germany

Moderate Risk

FDA Import Risk Assessment

49.0
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

7
Total Refusals
3
Unique Violations
10/31/2022
Latest Refusal
2/10/2002
Earliest Refusal

Score Breakdown

Violation Severity
78.9×40%
Refusal Volume
33.5×30%
Recency
35.6×20%
Frequency
3.4×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

756×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

1182×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

161×

DIRECTIONS

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it is a device whose label appears to not bear adequate directions for use.

Refusal History

DateProductViolationsDivision
10/31/2022
62IIY67VINCRISTINE SULFATE (ANTI-NEOPLASTIC)
75UNAPPROVED
Division of Northeast Imports (DNEI)
10/31/2022
56HIK24DOXORUBICIN HYDROCHLORIDE (ANTITUMOR)
75UNAPPROVED
Division of Northeast Imports (DNEI)
10/31/2022
62IIY67VINCRISTINE SULFATE (ANTI-NEOPLASTIC)
75UNAPPROVED
Division of Northeast Imports (DNEI)
10/31/2022
56HIK24DOXORUBICIN HYDROCHLORIDE (ANTITUMOR)
75UNAPPROVED
Division of Northeast Imports (DNEI)
2/8/2012
62IDP60THIOTEPA (ANTI-NEOPLASTIC)
118NOT LISTED
75UNAPPROVED
Baltimore District Office (BLT-DO)
11/29/2005
66VBK99MISCELLANEOUS PATENT MEDICINES, ETC.
118NOT LISTED
16DIRECTIONS
New York District Office (NYK-DO)
2/10/2002
61ADA06CHLOROQUINE PHOSPHATE (ANTI-AMEBIC)
75UNAPPROVED
Cincinnati District Office (CIN-DO)

Frequently Asked Questions

What is Thymoorgan Pharmazie Gmbh's FDA import refusal history?

Thymoorgan Pharmazie Gmbh (FEI: 3002320821) has 7 FDA import refusal record(s) in our database, spanning from 2/10/2002 to 10/31/2022.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Thymoorgan Pharmazie Gmbh's FEI number is 3002320821.

What types of violations has Thymoorgan Pharmazie Gmbh received?

Thymoorgan Pharmazie Gmbh has been cited for 3 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Thymoorgan Pharmazie Gmbh come from?

All FDA import refusal data for Thymoorgan Pharmazie Gmbh is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.